Neutrophils are mediators of metastatic prostate cancer progression in bone

Bone metastatic prostate cancer (BM-PCa) significantly reduces overall patient survival and is currently incurable. Current standard immunotherapy showed promising results for PCa patients with metastatic, but less advanced, disease (i.e., fewer than 20 bone lesions) suggesting that PCa growth in bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Costanzo-Garvey, Diane L., Keeley, Tyler, Case, Adam J., Watson, Gabrielle F., Alsamraae, Massar, Yu, Yangsheng, Su, Kaihong, Heim, Cortney E., Kielian, Tammy, Morrissey, Colm, Frieling, Jeremy S., Cook, Leah M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230043/
https://www.ncbi.nlm.nih.gov/pubmed/32114681
http://dx.doi.org/10.1007/s00262-020-02527-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230043/
https://www.ncbi.nlm.nih.gov/pubmed/32114681
http://dx.doi.org/10.1007/s00262-020-02527-6

Ejemplares similares